جست‌وجوی استاد و پژوهشگر

Stephen Paradaمشاهده پروفایل

استاد

• Orthopedic Surgery
• Shoulder and Elbow Surgery
• Total Joint Arthroplasty
• +۵ مورد دیگر

Stephen Parada is a Professor at the Medical College of Georgia, with academic appointments in the Department of Orthopedic Surgery. He is actively involved in clinical education and research, contributing significantly to orthopedic surgery, particularly in shoulder and elbow arthroplasty and biomechanics. Research Interests: His work spans orthopedic surgery, biomechanics, surgical outcomes, and the application of artificial intelligence in patient education. He focuses on improving clinical outcomes in total joint replacement, understanding shoulder instability, and evaluating publication trends in orthopedic research. The recent publications indicate a strong trend toward evidence-based orthopedics, with emphasis on predictive modeling of surgical outcomes, implant longevity, and the role of digital tools in patient communication. His research bridges clinical practice with academic scholarship. Scientific Awards: AAOS Kappa Delta Award, AAOS, 2025 Resident Research Award, Georgia Orthopaedic Society, 2022 GME Exemplary Teaching Award, Medical College of Georgia, 2021 GME Exemplary Teaching Award, Medical College of Georgia, 2020 Teaching and Service: Dr. Parada teaches key surgical clerkships and orthopedic externships. He serves on the AAOS Exhibits Committee and holds leadership roles in the Georgia Shoulder & Elbow Society. His professional service includes roles in ASES, AANA, and AAOS annual meetings, reflecting active engagement in national orthopedic communities. Laboratories and Research Teams: He is involved in Orthopaedic Research at the Medical College of Georgia (2023–present), contributing to a collaborative environment focused on advancing musculoskeletal care through innovation and education.

Dominika Ignasiakمشاهده پروفایل

پژوهشگر

• Biomechanics
• Musculoskeletal Modeling
• Spinal Surgery
• +۳ مورد دیگر

Dr. Dominika Ignasiak is a Researcher affiliated with the Institute of Biomechanics at ETH Zürich. Her work focuses on spinal biomechanics, musculoskeletal modeling, and computational analysis of spinal pathologies. She contributes to understanding the biomechanical implications of surgical interventions, spinal deformities, and age-related changes in spinal alignment and loading. Her research integrates clinical data with advanced musculoskeletal modeling techniques, particularly in predicting postoperative outcomes and assessing spinal load distributions under dynamic conditions. Key areas include spinal stenosis, idiopathic scoliosis, and the biomechanics of spinal fusion surgery. Dr. Ignasiak collaborates on translational studies bridging computational simulations with clinical applications. Her publications emphasize the role of personalized models in optimizing surgical strategies and understanding degenerative spinal conditions. While no formal awards are listed, her contributions to spinal biomechanics research are evident through her active publication record in high-impact journals. Dr. Ignasiak is based at ETH Zürich’s Institute of Biomechanics, where she engages in cutting-edge research and contributes to both academic and clinical advancements in orthopedic biomechanics.

Kanwaljeet S. Anandمشاهده پروفایل

استاد

• Pediatric Pain and Stress Neurobiology
• Neonatal and Fetal Pain Assessment
• Biomarker Development
• +۳ مورد دیگر

Dr. Kanwaljeet S. Anand is a dual-appointed Professor of Pediatrics (Pediatric Critical Care) and Anesthesiology, Perioperative & Pain Medicine at Stanford University School of Medicine. As director of the Pain/Stress Neurobiology Lab and Jackson Vaughan Critical Care Research Fund, he serves as Editor-in-Chief of Pediatric Research and maintains active membership in Bio-X, MCHRI, and Wu Tsai Neurosciences Institute. Rhodes Scholar with D.Phil from University of Oxford Harvard postdoctoral fellowship and Boston Children's Hospital residency Founded Harmony Health Clinic - Arkansas' largest charitable medical-dental facility A translational researcher with 30+ years of impact, Dr. Anand established the first scientific framework for infant pain perception and developed novel pain assessment methodologies. Current research focuses on: Hair biomarker analysis for stress and social affiliation (cortisol/oxytocin) Machine learning systems for objective pain detection in non-verbal infants Biopsychosocial interventions for stress reduction in disadvantaged youth Neurotoxicity mechanisms of sedatives in developing brains Global NICU opioid usage patterns through the NeoOpioid Consortium His work has yielded over 260 publications and significant advances in: Pediatric pain management protocols Neonatal stress biomarker development Critical care neurobiology insights Community health initiatives AI-driven clinical decision support systems Scientific Recognition 9th Annual 'In Praise of Medicine' Public Address, Erasmus University (2014) Nightingale Excellence Award (2016) Honorary Doctorate from University of Örebro (2019) NIH SBIB-H82 Study Section Chair (2018) Multiple IASP and American Pain Society awards Swedish Academy of Medicine's Nils Rosén von Rosenstein Award (2009) St. Jude Endowed Chairholder (2010) As mentor to Med Scholar Anjali Gupta and advisor to numerous professional bodies, Dr. Anand maintains active clinical leadership in Pediatric Intensive Care while advancing computational approaches to pain detection through collaborations with Stanford's AI researchers.

Elizabeth Zhengمشاهده پروفایل

دانشیار

• Transplant Hepatology
• Liver Cancer
• Hepatitis B
• +۵ مورد دیگر

Elizabeth Zheng, MD, is an Associate Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine, where she specializes in transplant hepatology. She provides clinical care through the UCSF Liver Transplant Program and conducts research focused on improving access to liver care and liver-cancer screening for underserved populations. She co-founded the Asian Liver Health Center and is board-certified in transplant hepatology, gastroenterology, and internal medicine. Education & Training MD – New York Medical College, 2011 Internal Medicine Residency – Montefiore Medical Center (Albert Einstein College of Medicine affiliate), 2014 Gastroenterology Fellowship – Einstein Medical Center, Philadelphia, 2017 Transplant Hepatology Fellowship – UCSF, 2018 Research Interests Dr. Zheng’s scholarly work centers on two major themes: Expanding access to high-quality liver care among underserved and minority populations, particularly Asian Americans. Developing and validating practical strategies for liver-cancer surveillance, including ultrasound-based recall algorithms and real-world management of hepatocellular carcinoma. She has additional expertise in drug-induced liver injury related to herbal and dietary supplements, having authored multiple reviews and prospective analyses on this topic. Publication Trends Across more than a dozen peer-reviewed articles since 2010, Dr. Zheng has advanced knowledge in hepatocellular carcinoma surveillance, COVID-19-associated liver injury, and supplement-related hepatotoxicity. Her collaborative multicenter studies have informed evidence-based guidelines and public-health recommendations. Clinical & Outreach Roles Co-founder, Asian Liver Health Center Attending Transplant Hepatologist, UCSF Liver Transplant Program Multisite clinical practice locations in San Francisco (400 Parnassus Ave and satellite clinics)

Yan Maمشاهده پروفایل

استاد

• Missing Data Imputation
• Machine Learning
• Meta-Analysis
• +۱۲ مورد دیگر

Yan Ma serves as Professor and Chair of Biostatistics at the University of Pittsburgh, with additional appointments in Orthopaedic Surgery and Clinical and Translational Science. Previously, he was Professor and Vice Chair at George Washington University Milken Institute of Public Health (2014-2022) and Assistant Professor at Hospital for Special Surgery/Weill Cornell Medical College (2008-2014). His educational background includes: PhD in Statistics, University of Rochester (2008) MA in Statistics, University of Rochester (2004) MS in Mathematics, Syracuse University (2003) BS in Statistics, Beijing Normal University (2001) Ma's research centers on advanced statistical methodologies including missing data imputation, machine learning, meta-analysis, causal inference, and longitudinal methods, applied across orthopedics, anesthesiology, health disparities, and emergency medicine through team science and translational research frameworks. His publication trajectory demonstrates sustained innovation from methodological foundations (2008-2012) to contemporary applications in health disparities and machine learning (2016-2022), consistently addressing complex biomedical challenges through high-impact journals like JAMA and Health Services Research. His scientific recognition includes: ASA's Statistics in Epidemiology Young Investigator Award (2010) Interorganizational Team Science Award (2012) ORISE FDA Research Fellowship (2017) APHA Achievement in Academia Award Ma has secured R01 funding from NIH/AHRQ for missing data methods in health disparities research while serving as Associate Editor for ASA journals and reviewer for NIH/PCORI/VA panels, demonstrating leadership in statistical methodology development and interdisciplinary collaboration. His team-science approach bridges statistical innovation with clinical implementation across orthopedics and anesthesiology, driving evidence-based practice through methodological rigor and cross-disciplinary partnerships.

Steff Lewisمشاهده پروفایل

استاد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Steff Lewis is a Professor of Medical Statistics at the University of Edinburgh , affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine . She leads the statistics group at the Edinburgh Clinical Trials Unit and holds roles in the Deanery of Molecular, Genetic and Population Health Sciences . Her expertise spans meta-analysis, randomized trial design, and clinical trial governance, with involvement in Cochrane Collaboration and UK Clinical Research Collaboration initiatives. Education: MSc and PhD in Medical Statistics. Research Interests: Focuses on methodological advancements in clinical trial reporting (e.g., CONSORT and SPIRIT guidelines), cardiovascular outcomes (e.g., SCOT-HEART trial), stroke prevention (ASPIRING trial), and ethical data management. She actively contributes to international standards for trial protocols, anonymization practices, and statistical validation. Recent Contributions: Over 200 peer-reviewed articles and 37 ongoing projects, including leadership in trials assessing antiplatelet therapies, Paget’s disease interventions, and pediatric asthma treatments. Collaborates globally on guidelines for randomized trials and data-sharing protocols. Grants & Teams: Principal or co-investigator on projects funded by NIHR, BHF, and ESRC, including trials on iron therapy in critical care (INTACT-2) and cannabinoid treatments for endometriosis pain (ENDO-CAN). Leads multidisciplinary teams integrating statistical rigor with clinical innovation. Labs/Teams: Embedded within the Edinburgh Clinical Trials Unit and the Centre for Population Health Sciences , fostering collaborative research across molecular, genetic, and public health domains.

Byron Crapeمشاهده پروفایل

دانشیار

• Evidence-Based Medicine
• Infectious Diseases
• Chronic Diseases
• +۶ مورد دیگر

Byron Crape, PhD, MSPH, is an Associate Professor of Practice at the Nazarbayev University School of Medicine, Department of Biomedical Sciences. He has previously served as Assistant Professor of Practice at the same institution and has held academic positions at the American University of Armenia College of Health Sciences, Anton de Kom University School of Medicine in Suriname, and King Saud University College of Medicine. His extensive career spans global health roles with WHO, Johns Hopkins University, and the Maryland State Department of Health. Education: PhD in Infectious Disease Epidemiology, Johns Hopkins University (2006) MSPH in Biostatistics, Loma Linda University Health (1988) BS in Physics, University of Washington (1980) Research Interests: Dr. Crape's research focuses on Evidence-Based Medicine , Infectious Diseases , Chronic Diseases , Mental Health , and Environmental Health . He employs Population-Based Research Methodologies and Clinical Research approaches to address global health challenges, particularly in resource-limited settings. His work on Disaster Surveillance systems has been critical in managing public health emergencies. His recent publications demonstrate a strong focus on COVID-19 , neurological disorders , and environmental health impacts in Central Asia, especially Kazakhstan. The research spans from assessing the burden of Parkinson's disease to evaluating the neurotoxic effects of indoor air pollution from cooking. Scientific Awards: While specific awards are not detailed in the provided text, his significant contributions are evidenced by a substantial publication record and active research funding. Projects and Funding: Prerequisites for end-of-life care provision in Kazakhstan (2021-2025, PI) Effectiveness of preloaded combination nicotine replacement therapy on smoking cessation in Kazakhstan (2022-2024, Co-PI) Exposure to Cooking Ultrafine Particles and Neurodegenerative Diseases (2022-2024, Co-PI) Clinico-epidemiological assessment of COVID-19 infection in Kazakhstan (2021-2022, Co-Investigator) Longitudinal Tracking of COVID-19 seroprevalence in Kazakhstan (2021-2024, Co-Investigator) Laboratory and Team: Dr. Crape collaborates extensively with multidisciplinary teams across institutions, mentoring students and junior researchers. His projects involve partnerships with WHO, national ministries of health, and academic institutions worldwide, fostering a collaborative environment for global health research.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

• Pharmaceutical Care
• Interdisciplinary Collaboration
• Patient-Centered Care
• +۵ مورد دیگر

Veerle Foulon serves as full professor and dean of the Faculty of Pharmaceutical Sciences at KU Leuven, Belgium. She leads the Unit Clinical Pharmacology and Pharmacotherapy within the Department of Pharmaceutical and Pharmacological Sciences. Her institutional leadership roles include membership in the University Council, Academic Council, and Special Academic Council as dean, alongside positions in the Board for Alumni Relations and Biomedical Sciences Group Management. Leuven Centre for Health Humanities Leuven Interdisciplinary Centre for Meaning and Lived Religion LC&Y - KU Leuven Institute for Child and Youth LIVO – KU Leuven Institute for Educational Research LKI - KU Leuven Cancer Institute Her research centers on pharmaceutical care, interdisciplinary collaboration, patient-centered care, and rational pharmacotherapy. Key focus areas include medication safety during pregnancy through the BELpREG registry, antimicrobial stewardship in Ethiopian healthcare settings, and person-centered medication optimization for elderly patients in nursing homes. She emphasizes real-world data collection and interdisciplinary approaches to address critical gaps in medication safety for vulnerable populations. Analysis of her recent publications reveals dominant themes in pregnancy medication safety (particularly via the BELpREG cohort), nursing home medication pathways, and antimicrobial resistance interventions. Her work consistently involves large-scale international collaborations across Europe and Ethiopia, addressing systemic challenges in pharmaceutical care through mixed-methods designs and registry-based studies. As principal investigator on major funded projects extending to 2028—including antimicrobial resistance initiatives in Ethiopia and pregnancy medication safety studies—she directs substantial research grants. Her leadership in interdisciplinary consortia drives innovation in medication optimization, though specific doctoral advisees are not documented in the provided materials. Current projects demonstrate strong translational focus with direct clinical implementation pathways. Embedded within multiple Leuven research institutes, she fosters cross-disciplinary collaborations through the BELpREG consortium and antimicrobial stewardship networks. Her work actively involves partnerships with Ethiopian tertiary hospitals, European pregnancy registries, and Belgian nursing home networks to develop and implement evidence-based pharmaceutical care models.

• Wound Healing & Tissue Repair
• Pressure Ulcer Prevention
• Nursing & Midwifery Education
• +۴ مورد دیگر

Prof. Zena Moore is a renowned academic and clinician serving as Professor and Head of the School of Nursing & Midwifery at RCSI, University of Medicine and Health Sciences. She holds adjunct professorships at Curtin University (Australia), Griffith University (Australia), Cardiff University (UK), Ghent University (Belgium), and Fakeeh College for Medical Sciences (Saudi Arabia). Her research focuses on wound healing, pressure ulcer prevention, and nursing education, with over 300 publications. She leads the Skin Wounds and Trauma (SWaT) Research Centre and chairs multiple international bodies including the European Pressure Ulcer Advisory Panel. Education: PhD in Wound Healing (RCSI), MSc in Leadership in Health Education (RCSI), MSc in Wound Healing (University of Wales), FFNMRCSI, and Diplomas in Management and Nursing. Research Interests: Wound pathophysiology, pressure ulcer risk assessment, technologies for early detection, and healthcare equity. Awards: 2022 Lifetime Achievement Award from World Union of Wound Healing Societies. Her work spans over 50 funded projects, including grants from Science Foundation Ireland and the National Health and Medical Research Council. She has supervised numerous research projects on topics like pressure ulcer prevention algorithms and eHealth interventions.

Stacy L. Pinelesمشاهده پروفایل

استاد

• Pediatric Ophthalmology
• Neuro-Ophthalmology
• Strabismus
• +۵ مورد دیگر

Stacy L. Pineles, MD, MS is a Professor of Ophthalmology and Residency Program Director at the Stein Eye Institute, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She also serves as Chair-Elect of the Pediatric Eye Disease Investigator Group (PEDIG), a collaborative network funded by the National Eye Institute dedicated to facilitating multicenter clinical research in strabismus, amblyopia, and other eye disorders affecting children. Dr. Pineles is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center as hospital affiliations. Dr. Pineles completed her medical training at the University of Pennsylvania in 2004, followed by ophthalmology residency at UCLA (2005-2008), pediatric ophthalmology fellowship at UCLA (2009), neuro-ophthalmology fellowship at the University of Pennsylvania (2010), and a Master's degree in Clinical Investigation at UCLA (2013). She joined the UCLA faculty in 2010 and became Residency Program Director in 2017. Her primary research interests focus on pediatric neuro-ophthalmology and strabismus, with specific emphasis on binocular vision in children and adults with eye misalignment, systemic effects of pediatric eye disease, and clinical trials in pediatric ophthalmology. Dr. Pineles serves as principal investigator of an NIH-sponsored multicenter study of pediatric optic neuritis. She runs an NIH-sponsored research program evaluating binocular vision in children and adults with eye misalignment. Analysis of Dr. Pineles' publications reveals consistent research activity in pediatric ophthalmology, neuro-ophthalmology, and strabismus, with particular focus on binocular vision, optic neuritis, and surgical outcomes. Her work spans clinical trials, diagnostic accuracy studies, and innovative surgical techniques, demonstrating expertise in both clinical care and research methodology. Super Doctors® Southern California, 2022-2025 AAPOS Young Investigator Award, 2019 University of California OptumLabs Research Credit Award, 2018 Appointment of Jerome and Joan Snyder Chair in Ophthalmology, 2017 American Academy of Ophthalmology Achievement Award, 2016 AAPOS Honors Award, 2016 Dr. Pineles serves on numerous professional committees within the American Academy of Ophthalmology, American Association of Pediatric Ophthalmology and Strabismus, and the North American Neuro-Ophthalmology Society. She travels regularly nationally and internationally to speak on topics related to her research in pediatric neuro-ophthalmology. As Residency Program Director since 2017, she oversees ophthalmology training at UCLA. She is author of more than 100 peer-reviewed publications and 10 book chapters. Dr. Pineles leads the Pediatric Ophthalmology division at the Stein Eye Institute, which is part of one of the world's leading centers of vision science. Her research program includes multicenter clinical trials and NIH-sponsored studies evaluating binocular vision and pediatric optic neuritis. She actively collaborates with the Pediatric Eye Disease Investigator Group (PEDIG), a network of over 100 participating sites with more than 300 pediatric ophthalmologists and optometrists across the United States, Canada, and the United Kingdom.

Andrew T Arndtمشاهده پروفایل

استادیار بالینی

• Thoracic Surgery
• Lung Cancer
• Chest Wall Tumors
• +۳ مورد دیگر

Andrew T Arndt, MD is a Clinical Assistant Professor in the Department of Surgery specializing in Thoracic Surgery at Northwestern University's Feinberg School of Medicine. Board certified by the American Board of Thoracic Surgery, he maintains clinical practice at Northwestern Medicine Central DuPage Hospital and holds active memberships in the Society of Thoracic Surgeons (2023-present) and American Board of Thoracic Surgery (2022-present). His research concentrates on advancing thoracic surgical oncology through investigations into lung cancer resection outcomes, chest wall tumor management, minimally invasive techniques, and pneumothorax recurrence factors. Current work emphasizes evidence-based risk stratification and surgical innovation to improve patient outcomes in complex thoracic pathologies. Recent publications demonstrate consistent focus on surgical registry analysis (2021), consensus development for thoracoscopic training (2021), systematic reviews of rare chest wall malignancies (2023), and identification of lifestyle-related recurrence risks (2021). This trajectory highlights growing contributions to thoracic surgical guidelines and evidence-based practice standards. Dr. Arndt serves as a consultant for Intuitive Surgical, Inc. (2024 disclosures) while maintaining active clinical and academic roles. No formal advisees or research grants are listed in current profile materials. Within Northwestern's Department of Surgery, he contributes to the Thoracic Surgery division's clinical and research missions, particularly in advancing minimally invasive approaches and multidisciplinary management of complex thoracic conditions through collaborative registry studies and consensus initiatives.

Anne-Mette Hvasمشاهده پروفایل

استاد

• Hematology
• Thrombosis and Hemostasis
• Platelet Function
• +۷ مورد دیگر

Anne-Mette Hvas is Professor and Dean at the Faculty of Health, Aarhus University, Denmark, where she leads academic and administrative initiatives in health sciences. Her role places her at the forefront of institutional strategy, research development, and interdisciplinary collaboration within clinical and translational medicine. Research Interests: Her work spans hematology, coagulation, platelet biology, neonatal hemostasis, and endocrinology. She investigates thrombotic and bleeding disorders in clinical contexts such as nephrotic syndrome, pregnancy, cancer surgery, and stroke. Her research integrates physiological, pharmacological, and clinical perspectives to improve patient outcomes. The recent publications reflect a strong focus on thrombin generation, platelet reactivity, endothelial dysfunction, and red blood cell behavior in acute and chronic conditions. These studies often involve multicenter collaborations and contribute to evidence-based practices in thromboprophylaxis, surgical safety, and stroke management. Scientific Contributions: Active research in hemostasis and thrombosis across diverse patient populations Leadership in clinical studies on anticoagulation, HIPEC, and neonatal platelet function Investigations into hormonal and cardiovascular aspects of Turner syndrome Advising and Grants: While specific advisees are not listed, her leadership in multiple funded research projects suggests mentorship of junior researchers and clinicians. She has led projects on platelet function in preterm neonates and coagulation in surgical oncology, indicating grant acquisition and team coordination capabilities. Labs and Teams: Though specific lab names are not mentioned, her work implies collaboration with clinical research teams in hematology, neonatology, oncology, and obstetrics at Aarhus University Hospital and affiliated centers.

Benjamin Shoreمشاهده پروفایل

دانشیار

• Pediatric Orthopedic Surgery
• Cerebral Palsy
• Hip Reconstruction
• +۳ مورد دیگر

Benjamin Shore, MD, MPH, FRCSC, is Associate Professor of Orthopedic Surgery at Harvard Medical School and a practicing pediatric orthopedic surgeon at Boston Children’s Hospital. He serves as Co-Director of the Cerebral Palsy and Spasticity Center and Director of the Pediatric Orthopaedic Surgery Fellowship. Education and Training Undergraduate: Biology, University of Victoria, 1999 MPH: Harvard School of Public Health, 2013 MD: University of Western Ontario, 2003 Residency: Orthopedic Surgery, University of Western Ontario, 2008 Fellowship 1: Pediatric Orthopedics, Royal Children's Hospital, Melbourne, 2009 Fellowship 2: Pediatric Orthopedics, Boston Children’s Hospital, 2010 Research Focus Dr. Shore’s research centers on improving outcomes for children with cerebral palsy and other complex musculoskeletal conditions. His work spans hip surveillance and reconstruction, gait abnormalities, trauma care, and the implementation of evidence-based surgical pathways. He has pioneered investigations into anesthesia protocols, infection prevention, and patient-reported outcome measures for pediatric orthopedic populations. Scientific Awards St. Giles Young Investigator Award (POSNA) Clinician Scientist Development Program Award (CSDP) Charles H. Hood Foundation Child Health Research Award Leadership & Multi-Disciplinary Teams At Boston Children’s Hospital, Dr. Shore leads a high-performance team within the Cerebral Palsy and Spasticity Center that integrates orthopedic surgery, neurology, physical therapy, and social work to deliver patient- and family-centered care. He mentors fellows and residents and actively contributes to national consensus projects using Delphi methodology to standardize surgical indications in cerebral palsy.

Jacob Youngمشاهده پروفایل

استادیار

• Neuro-oncology
• Glioblastoma
• Brain Tumor Immunology
• +۶ مورد دیگر

Jacob Young, MD, is an Assistant Professor in the Department of Neurological Surgery at the University of California, San Francisco (UCSF) School of Medicine and a Principal Investigator in the UCSF Brain Tumor Center. His clinical practice focuses on neurosurgical management of adult brain tumors including gliomas, metastatic tumors, and meningiomas, utilizing advanced brain mapping techniques to preserve critical motor, language, and sensory functions during resection. Dr. Young's educational background includes a BS in Neuroscience from Duke University (2012), an MD from the University of Chicago Pritzker School of Medicine where he was elected to Alpha Omega Alpha Honor Medical Society (2017), and a neurosurgery residency at UCSF (2017-2024). His research program integrates laboratory investigations with clinical trials to address fundamental challenges in brain tumor treatment. His primary research interests center on understanding glioblastoma immune microenvironment dynamics and developing innovative therapeutic strategies. Key focus areas include: First-in-human clinical trials of novel immunotherapies Focused ultrasound-mediated blood-brain barrier disruption to enhance drug delivery Longitudinal molecular profiling of tumor evolution during treatment AI-driven tools for patient care navigation and clinical trial assessment Prospective outcomes research through the RANO resect group and NeuroPoint Alliance His work bridges fundamental tumor biology with translational applications to overcome treatment resistance. Analysis of Dr. Young's 15 most recent publications (2023-2025) reveals a strong emphasis on surgical innovation, tumor immunology, and molecular characterization. Key trends include: development of prognostic classification systems for resection extent, investigation of glioma-neuronal circuit interactions driving immunosuppression, and optimization of drug delivery strategies. His collaborative work within the RANO consortium establishes evidence-based surgical guidelines while his lab's focus on microenvironmental factors informs next-generation immunotherapies. Dr. Young has received significant recognition including: Chan-Zuckerberg Physician Scientist Fellowship (2021-2022) ASCO Young Investigator Award (2022-2023) Andrew J. Lockhart Focused Ultrasound Fellowship (2023) Multiple Harold Rosegay Teaching Awards from UCSF Howard Naffziger Award for Clinical Excellence His research is supported by NIH, NCI, Focused Ultrasound Foundation, and AANS grants. As lab director, Dr. Young mentors a diverse team including PhD candidates like Edward Valenzuela (DSCB program) and specialists in immunology and neuro-oncology. His lab participates in the RANO resect group, ENCRAM research program, and NeuroPoint Alliance to advance clinical protocols. Current projects include developing intraoperative focused ultrasound prototypes, single-cell analysis of tumor evolution, and AI tools for patient navigation through care pathways. Future work focuses on translating microenvironment discoveries into combination therapies targeting treatment resistance mechanisms.